Asghar Naveed, Melik Wessam, Paulsen Katrine M, Pedersen Bendikte N, Bø-Granquist Erik G, Vikse Rose, Stuen Snorre, Andersson Sören, Strid Åke, Andreassen Åshild K, Johansson Magnus
School of Medical Sciences, Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, SE-70362 Örebro, Sweden.
Department of Virology, Division for Infection Control, Norwegian Institute of Public Health, N-0213 Oslo, Norway.
Vaccines (Basel). 2022 Oct 6;10(10):1667. doi: 10.3390/vaccines10101667.
Flaviviruses are a threat to public health and can cause major disease outbreaks. Tick-borne encephalitis (TBE) is caused by a flavivirus, and it is one of the most important causes of viral encephalitis in Europe and is on the rise in Sweden. As there is no antiviral treatment available, vaccination remains the best protective measure against TBE. Currently available TBE vaccines are based on formalin-inactivated virus produced in cell culture. These vaccines must be delivered by intramuscular injection, have a burdensome immunization schedule, and may exhibit vaccine failure in certain populations. This project aimed to develop an edible TBE vaccine to trigger a stronger immune response through oral delivery of viral antigens to mucosal surfaces. We demonstrated successful expression and post-translational processing of flavivirus structural proteins which then self-assembled to form virus-like particles in . We performed oral toxicity tests in mice using various plant species as potential bioreactors and evaluated the immunogenicity of the resulting edible vaccine candidate. Mice immunized with the edible vaccine candidate did not survive challenge with TBE virus. Interestingly, immunization of female mice with a commercial TBE vaccine can protect their offspring against TBE virus infection.
黄病毒对公众健康构成威胁,可引发重大疾病暴发。蜱传脑炎(TBE)由黄病毒引起,是欧洲病毒性脑炎的最重要病因之一,在瑞典呈上升趋势。由于尚无抗病毒治疗方法,接种疫苗仍然是预防TBE的最佳保护措施。目前可用的TBE疫苗基于在细胞培养中产生的福尔马林灭活病毒。这些疫苗必须通过肌肉注射给药,免疫接种程序繁琐,并且在某些人群中可能出现疫苗接种失败的情况。该项目旨在开发一种可食用的TBE疫苗,通过将病毒抗原口服递送至粘膜表面来引发更强的免疫反应。我们证明了黄病毒结构蛋白的成功表达和翻译后加工,这些蛋白随后在[具体位置未提及]自组装形成病毒样颗粒。我们使用各种植物物种作为潜在的生物反应器对小鼠进行了口服毒性测试,并评估了所得可食用疫苗候选物的免疫原性。用可食用疫苗候选物免疫的小鼠在接受TBE病毒攻击后未能存活。有趣的是,用商业TBE疫苗免疫雌性小鼠可以保护它们的后代免受TBE病毒感染。